Ranitidine Capsules is the generic version of Zantac GELdose, a treatment for heartburn and indigestion. Geneva will begin shipping 150 and 300 mg dosages immediately. Geneva is part of the Global Generics sector of Novartis.
In April of 2020 the FDA called for the removal of prescription and over the counter ranitidine products. The decision followed an investigation into the potential contamination of ranitidine products, from the known carcinogen N-nitrosodimethylamine (NDMA). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. As a result of the market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S